Recently, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and novel renin-angiotensin-aldosterone system (RAAS) inhibitors have been the primary treatment methods for CKD. The gene discussed is REN; the disease is chronic kidney disease.